STUDIES ADDRESSING CLINICALLY RELEVANT QUESTIONS ABOUT KETONES AND THE USE OF CONTINUOUS KETONE MONITORING IN TYPE 1 DIABETES SRA and IDDP applications may request up to a total of $750,000 over a maximum of two years. - Wednesday November 12, 2025 (LOI) Breakthrough T1D, US The aim is to address clinically relevant questions about ketones and the use of CKM in T1D.